 There are three ideas that I would like to share with you at the end of this 2050 year and the celebration of those 25 years. The first is about the past. The EMCDDA has become a trusted source of information for all its stakeholders. And this is mainly thanks to a unique network of expertise that has been built around the Retox Network and the early warning system and new psychoactive substance. The second is about the present and the COVID-19 pandemic that of course had an impact on the drug market, on the services to people who are using drugs, but also on EMCDDA. We have been extremely resilient and innovative. And the third is about the future. We are building a new business model and this business model will be based on digital transformation that has been boosted by the pandemic this year and also more co-production with our main partners and stakeholders. This is what allows me to tell you that we are ready for the next 25 years. Thank you.